Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-049813

See Remarks sold 200,650 shares at an average $100.51 ($20,167,954)

  • See Remarks acquired 200,650 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lyon Joseph Douglas See Remarks 2025-03-31 Option exercise 10b5-1 +35,000 $13.56 $474,600 44,009 D
Lyon Joseph Douglas See Remarks 2025-03-31 Option exercise 10b5-1 +75,000 $16.52 $1,239,000 119,009 D
Lyon Joseph Douglas See Remarks 2025-03-31 Option exercise 10b5-1 +40,000 $15.82 $632,800 159,009 D
Lyon Joseph Douglas See Remarks 2025-03-31 Option exercise 10b5-1 +50,000 $19.26 $963,000 209,009 D
Lyon Joseph Douglas See Remarks 2025-03-31 Sale 10b5-1 −162,008 $100.22 $16,236,571 47,001 D
Lyon Joseph Douglas See Remarks 2025-03-31 Sale 10b5-1 −32,942 $101.37 $3,339,416 14,059 D
Lyon Joseph Douglas See Remarks 2025-03-31 Sale 10b5-1 −5,050 $102.48 $517,523 9,009 D
Lyon Joseph Douglas See Remarks 2025-04-01 Option exercise 10b5-1 +650 $13.56 $8,814 9,659 D
Lyon Joseph Douglas See Remarks 2025-04-01 Sale 10b5-1 −650 $114.53 $74,443 9,009 D
Derivatives
Lyon Joseph Douglas See Remarks 2025-03-31 Option exercise · Stock option (right to buy) 10b5-1 −35,000 56,571 D
Lyon Joseph Douglas See Remarks 2025-03-31 Option exercise · Stock option (right to buy) 10b5-1 −75,000 0 D
Lyon Joseph Douglas See Remarks 2025-03-31 Option exercise · Stock option (right to buy) 10b5-1 −40,000 0 D
Lyon Joseph Douglas See Remarks 2025-03-31 Option exercise · Stock option (right to buy) 10b5-1 −50,000 50,000 D
Lyon Joseph Douglas See Remarks 2025-04-01 Option exercise · Stock option (right to buy) 10b5-1 −650 55,921 D
Open-market sales · 200,650 sh · avg $100.51 · $20,167,954
Loading xslF345X05/ownership.xml…